Antimicrobial Mechanism and Enlightenment to New Antimicrobial Agents
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanisms and Structural Biology of Antibiotic Action".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 1672
Special Issue Editors
Interests: antimicrobial resistance; anti-virulence therapy; natural products with antibacterial activity; Gram-negative microbe; ESKAPE pathogens; diagnosis
Interests: bacteriophage; endolysin; peptidoglycan hydrolase; protein engineering; directed evolution; natural products
Special Issue Information
Dear Colleagues,
The increased emergence of antimicrobial resistance (AMR) is a major healthcare problem worldwide. AMR is one of the outcomes of long-term interaction of microorganisms with their living environments. Understanding the mechanisms and drivers of AMR will provide a scientific basis and strategy to combat the threat to human health and biosecurity from AMR. In addition, AMR necessitates the development of novel antimicrobial agents with different mechanisms of action from traditional antibiotics. These alternatives include natural products (e.g., flavonoids, phytochemicals, and polysaccharides), phage and phage-derived endolysins, vaccines, probiotics, antibodies, peptides, and other solutions.
The aim of this Special Issue is to present the status of and future trends in tracking antimicrobial mechanism and the enlightenment for new antimicrobial agents. This Special Issue collects manuscripts that improve our understanding of AMR and the development of new antimicrobial agents. Manuscripts about antimicrobial mechanisms, the discovery of novel antimicrobial agents (including but not limited to natural products, polysaccharides, phage and phage lysin, vaccines, probiotics, antibodies, peptides, and proteins), new methods for AMR surveillance, diagnosis, and antimicrobial screening, experimental therapy of antimicrobial agents in vitro and in vivo, and the antibacterial, antibiofilm, and antifungal applications of these agents in the related field of microbiology, biotechnology, and pharmacology are welcome for submission.
Prof. Dr. Hang Yang
Prof. Dr. Daniel C. Nelson
Prof. Dr. Krystyna Dąbrowska
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- antimicrobial agents
- natural products
- nontraditional antibiotics
- experimental therapy
- antibiofilm
- diagnosis
- mechanisms of action
